THE RELATIONSHIP BETWEEN SMOKING HABITS AND THE INCIDENCE OF CHRONIC URTICARIA IN CIVITAS WIDYA MANDALA CATHOLIC UNIVERSITY SURABAYA

Erna Harijati, Maria Patricia Dian Putri, Paul L Tahalele, Antonius Kevin Khoesasih

Abstract


Background: Urticaria is a heterogeneous disease with multiple causative factors. A thorough literature research has revealed a very limited amount of evidence about the effects of smoking and alcohol consumption habits on the clinical characteristics of urticaria.. Atopic allergic which mean urticaria can affect all populations, but is most common in those aged between 20 to >60 years. Smoking has been reported to play a role in the onset of Urticaria. Substances in cigarette smoke can interact with body cells, resulting in the formation of free radicals or Reactive Oxygen Species (ROS).

Objective: To see the relationship between smoking habit and the incidence of chronic urticaria among civitas at Widya Mandala Surabaya.

Methods: The method used in this study was a case-control study by taking a population of civitas at the Widya Mandala Surabaya who had smoking history from 2020 to 2023. A sample of 94 people was obtained who had met the inclusion and exclusion criteria of the study. The sample of this study was divided into two groups consisting of a case group and a control group.

Results: The results of the Contigency Coefficient Correlation test showed a significant p value of 0.031 <0.05, which means that there is an important correlation between smoking and the incidence of chronic urticaria among civitas at the Widya Mandala Surabaya.

Conclusion: It is proven that there is a relationship between smoking and the incidence of chronic urticaria in civitas of Widya Mandala Surabaya.


Save to Mendeley


Keywords


Smoking habit; chronic urticaria; civitas university

Full Text:

PDF PDF

References


Zuberbier, T., Balke, M., Worm, M., Edenharter, G. & Maurer, M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin. Exp. Dermatol. 35, 869–873 (2010).

Lee, S. J. et al. Prevalence and risk factors of urticaria with a focus on chronic urticaria in children. Allergy Asthma Immunol. Res. 9, 212–219 (2017).

Church, M. K., Kolkhir, P., Metz, M. & Maurer, M. The role and relevance of mast cells in urticaria. Immunol. Rev. 282, 232–247 (2018).

Zuberbier, T. et al. The international EAACI/GA²LEN/ EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 77, 734–766 (2022). This update and revision of the international guideline for urticaria developed by 64 experts from 31 countries covers the definition and classification of urticaria and outlines expertguided and evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria.

Kolkhir, P. & Maurer, M. in Urticaria and Angioedema (eds Zuberbier, T., Grattan, C. & Maurer, M.) 77–107 (Springer International, 2021).

Weller, K. et al. Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany. J. Eur. Acad. Dermatol. Venereol. 36, 91–99 (2022).

Parisi, C. A., Ritchie, C., Petriz, N., Torres, C. M. & Gimenez-Arnau, A. Chronic urticaria in a health maintenance organization of Buenos Aires, Argentina — new data that increase global knowledge of this disease. Bras. Dermatol. 93, 76–79 (2018).

Balp, M. M. et al. Burden of chronic urticaria relative to psoriasis in five European countries. J. Eur. Acad. Dermatol. Venereol. 32, 282–290 (2018).

Wertenteil, S., Strunk, A. & Garg, A. Prevalence estimates for chronic urticaria in the United States: a sex- and age-adjusted population analysis. J. Am. Acad. Dermatol. 81, 152–156 (2019).

Tayefi, M. et al. Chronic urticaria: a swedish registrybased cohort study on population, comorbidities and treatment characteristics. Acta Derm. Venereol. 102, adv00624 (2022).

Seo, J.-H. & Kwon, J.-W. Epidemiology of urticaria including physical urticaria and angioedema in Korea. Korean J. Intern. Med. 34, 418–425 (2019).

Xiao, Y. et al. The prevalence of atopic dermatitis and chronic spontaneous urticaria are associated with parental socioeconomic status in adolescents in China. Acta Derm. Venereol. 99, 321–326 (2019).

Kim, Y. S. et al. Prevalence and incidence of chronic spontaneous urticaria in the entire Korean adult population. Br. J. Dermatol. 178, 976–977 (2018).

Bal, F., Kahveci, M., Soyer, O., Sekerel, B. E. & Sahiner, U. M. Chronic inducible urticaria subtypes in children: clinical features and prognosis. Pediatr. Allergy Immunol. 32, 146–152 (2021)

Jadhav, R., Alcala, E., Sirota, S. & Capitman, J. Risk factors for acute urticaria in central California. Int. J. Environ. Res. Public Health 18, 3728 (2021).

Peck, G. et al. Global epidemiology of urticaria: increasing burden among children, females and low-income regions. Acta Derm. Venereol. 101, adv00433 (2021).

Thomsen, S. F., van der Sluis, S., Kyvik, K. O. & Backer, V. Urticaria in monozygotic and dizygotic twins. J. Allergy 2012, 125367 (2012).

Rosman, Y. et al. Characterization of chronic urticaria and associated conditions in a large population of adolescents. J. Am. Acad. Dermatol. 81, 129–135 (2019).

Kanani A, Betschel SD, Warrington R. Urticaria and angioedema. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):59.

Jain S. pathogenesis of chronic urticaria: an overview. Dermatol Res pract. 2014;2014:674709.

Asero R, Tedeschi A, Marzano Av, Cugno M. Chronic urticaria: a focus on pathogenesis. f1000Res. 2017;6:1095.

Puxeddu I, pratesi f, Ribatti D, Migliorini p. Mediators of inflammation and angiogenesis in chronic spontaneous urticaria: are they potential biomarkers of the disease? Mediators Inflamm. 2017;2017:4123694.

Tedeschi A, Kolkhir p, Asero R, pogorelov D, Olisova O, Kochergin N, et al. Chronic urticaria and coagulation: pathophysiological and clinical aspects. Allergy. 2014;69(6):683-91.

Krystel-Whittemore M, Dileepan KN, Wood JG. Mast cell: a multi-functional master cell. front Immunol. 2016;6:620.

Givi ME, Blokhuis BR, Da Silva CA, Adcock I, Garssen J, folkerts G, et al. Cigarette smoke suppresses the surface expression of c-kit and fcεRI on mast cells. Mediators Inflamm. 2013;2013:813091.

Barua RS, Sharma M, Dileepan KN. Cigarette smoke amplifies inflammatory response and atherosclerosis progression through activation of the H1RTLR2/4-COX2 axis. front Immunol. 2015;6:572.

Wei XM, Kim HS, Kumar RK, Heywood GJ, Hunt JE, McNeil Hp, et al. Effects of cigarette smoke on degranulation and NO production by mast cells and epithelial cells. Respir Res. 2005;6(1):108.

Mishra NC, Rir-sima-ah J, Boyd RT, Singh Sp, Gundavarapu S, Langley RJ, et al. Nicotine inhibits fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors. J Immunol. 2010;185(1):588-96.

Givi ME, Blokhuis BR, Da Silva CA, Adcock I, Garssen J, folkerts G, et al. Cigarette smoke suppresses the surface expression of c-kit and fcεRI on mast cells. Mediators Inflamm. 2013;2013:813091.




DOI: https://doi.org/10.33508/jwmj.v6i3.5760

Refbacks

  • There are currently no refbacks.